Liver Injury/Regeneration

You have full text access to this OnlineOpen article

In vivo phosphoenolpyruvate carboxykinase promoter mapping identifies disrupted hormonal synergism as a target of inflammation during sepsis in mice†

  1. Evgeny Chichelnitskiy1,
  2. Alexandros Vegiopoulos1,‡,
  3. Mauricio Berriel Diaz1,‡,
  4. Anja Ziegler1,
  5. Anna Kleiman2,
  6. Alexander Rauch2,
  7. Jan Tuckermann2,
  8. Stephan Herzig1,*

Article first published online: 4 AUG 2009

DOI: 10.1002/hep.23194

Issue

Hepatology

Hepatology

Volume 50, Issue 6, pages 1963–1971, December 2009

Additional Information

How to Cite

Chichelnitskiy, E., Vegiopoulos, A., Diaz, M. B., Ziegler, A., Kleiman, A., Rauch, A., Tuckermann, J. and Herzig, S. (2009), In vivo phosphoenolpyruvate carboxykinase promoter mapping identifies disrupted hormonal synergism as a target of inflammation during sepsis in mice. Hepatology, 50: 1963–1971. doi: 10.1002/hep.23194

Author Information

  1. 1

    Emmy Noether and Marie Curie Research Group Molecular Metabolic Control, DKFZ-ZMBH Alliance, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany

  2. 2

    Research Group Tissue-specific Hormone Action, Leibniz Institute for Age Research — Fritz Lipmann Institute, Jena, Germany

  1. ‡

    These authors contributed equally to this study.

*German Cancer Research Center, DKFZ-ZMBH Alliance, Molecular Metabolic Control, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 20 NOV 2009
  2. Article first published online: 4 AUG 2009
  3. Accepted manuscript online: 4 AUG 2009 12:00AM EST
  4. Manuscript Accepted: 18 JUL 2009
  5. Manuscript Received: 5 MAR 2009

Funded by

  • Deutsche Forschungsgemeinschaft. Grant Numbers: He3260/2-1, Tu220/3
  • European Foundation for the Study of Diabetes
  • Marie Curie Excellence Grant (European Commission)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (411K)

References

  • 1
    Consoli A. Role of liver in pathophysiology of NIDDM. Diabetes Care 1992; 15: 430–441.
  • 2
    Hanson RW, Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 1997; 66: 581–611.
  • 3
    Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annu Rev Nutr 1999; 19: 379–406.
  • 4
    Roesler WJ, Vandenbark GR, Hanson RW. Identification of multiple protein binding domains in the promoter-regulatory region of the phosphoenolpyruvate carboxykinase (GTP) gene. J Biol Chem 1989; 264: 9657–9664.
  • 5
    Short JM, Wynshaw-Boris A, Short HP, Hanson RW. Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. II. Identification of cAMP and glucocorticoid regulatory domains. J Biol Chem 1986; 261: 9721–9726.
  • 6
    Park EA, Gurney AL, Nizielski SE, Hakimi P, Cao Z, Moorman A, et al. Relative roles of CCAAT/enhancer-binding protein beta and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP). J Biol Chem 1993; 268: 613–619.
  • 7
    Liu JS, Park EA, Gurney AL, Roesler WJ, Hanson RW. Cyclic AMP induction of phosphoenolpyruvate carboxykinase (GTP) gene transcription is mediated by multiple promoter elements. J Biol Chem 1991; 266: 19095–19102.
  • 8
    Quinn PG, Granner DK. Cyclic AMP-dependent protein kinase regulates transcription of the phosphoenolpyruvate carboxykinase gene but not binding of nuclear factors to the cyclic AMP regulatory element. Mol Cell Biol 1990; 10: 3357–3364.
  • 9
    Imai E, Miner JN, Mitchell JA, Yamamoto KR, Granner DK. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 1993; 268: 5353–5356.
  • 10
    Imai E, Stromstedt PE, Quinn PG, Carlstedt-Duke J, Gustafsson JA, Granner DK. Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1990; 10: 4712–4719.
  • 11
    Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003; 423: 550–555.
  • 12
    Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001; 413: 179–183.
  • 13
    Hofmann CA, Edwards CW 3rd, Hillman RM, Colca JR. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression. Endocrinology 1992; 130: 735–740.
  • 14
    Friedman JE, Sun Y, Ishizuka T, Farrell CJ, McCormack SE, Herron LM, et al. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. J Biol Chem 1997; 272: 31475–31481.
  • 15
    Valera A, Pujol A, Pelegrin M, Bosch F. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 1994; 91: 9151–9154.
  • 16
    Hill M, McCallum R. Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment. J Clin Invest 1991; 88: 811–816.
  • 17
    Hill MR, McCallum RE. Identification of tumor necrosis factor as a transcriptional regulator of the phosphoenolpyruvate carboxykinase gene following endotoxin treatment of mice. Infect Immun 1992; 60: 4040–4050.
  • 18
    Waltner-Law M, Daniels MC, Sutherland C, Granner DK. NF-kappa B inhibits glucocorticoid and cAMP-mediated expression of the phosphoenolpyruvate carboxykinase gene. J Biol Chem 2000; 275: 31847–31856.
  • 19
    Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001; 413: 131–138.
  • 20
    He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998; 95: 2509–2514.
  • 21
    Bokar JA, Roesler WJ, Vandenbark GR, Kaetzel DM, Hanson RW, Nilson JH. Characterization of the cAMP responsive elements from the genes for the alpha-subunit of glycoprotein hormones and phosphoenolpyruvate carboxykinase (GTP). Conserved features of nuclear protein binding between tissues and species. J Biol Chem 1988; 263: 19740–19747.
  • 22
    Scott DK, Stromstedt PE, Wang JC, Granner DK. Further characterization of the glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. The role of the glucocorticoid receptor-binding sites. Mol Endocrinol 1998; 12: 482–491.
  • 23
    Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, et al. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 1994; 43 Pt A: 161–189.
  • 24
    Berriel Diaz M, Krones-Herzig A, Metzger D, Ziegler A, Vegiopoulos A, Klingenspor M, et al. Nuclear receptor cofactor receptor interacting protein 140 controls hepatic triglyceride metabolism during wasting in mice. HEPATOLOGY 2008; 48: 782–791.
  • 25
    Klingmuller U, Bauer A, Bohl S, Nickel PJ, Breitkopf K, Dooley S, et al. Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. IEEE Proc Syst Biol 2006; 153: 433–447.
  • 26
    Zschiedrich I, Hardeland U, Krones-Herzig A, Berriel Diaz M, Vegiopoulos A, Muggenburg J, et al. Coactivator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression. Blood 2008; 112: 264–276.
  • 27
    Rudiger A, Stotz M, Singer M. Cellular processes in sepsis. Swiss Med Wkly 2008; 138: 629–634.
  • 28
    Vriesendorp TM, van Santen S, DeVries JH, de Jonge E, Rosendaal FR, Schultz MJ, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006; 34: 96–101.
  • 29
    Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998; 92: 829–839.
  • 30
    Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, Gonzalez FJ, et al. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci U S A 2003; 100: 4012–4017.
  • 31
    Angrand PO, Coffinier C, Weiss MC. Response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids depends on the integrity of the cAMP pathway. Cell Growth Differ 1994; 5: 957–966.
  • 32
    Yan J, Gao Z, Yu G, He Q, Weng J, Ye J. Nuclear corepressor is required for inhibition of phosphoenolpyruvate carboxykinase expression by tumor necrosis factor-alpha. Mol Endocrinol 2007; 21: 1630–1641.
  • 33
    Handschin C, Choi CS, Chin S, Kim S, Kawamori D, Kurpad AJ, et al. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. J Clin Invest 2007; 117: 3463–3474.
  • 34
    Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003; 100: 8466–8471.
  • 35
    Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008; 454: 463–469.
  • 36
    Palomer X, Alvarez-Guardia D, Rodriguez-Calvo R, Coll T, Laguna JC, Davidson MM, et al. TNF-{alpha} reduces PGC-1{alpha} expression through NF-{kappa}B and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc Res 2008.
  • 37
    Jitrapakdee S, St Maurice M, Rayment I, Cleland WW, Wallace JC, Attwood PV. Structure, mechanism and regulation of pyruvate carboxylase. Biochem J 2008; 413: 369–387.
  • 38
    Hammon HM, Philipona C, Zbinden Y, Blum JW, Donkin SS. Effects of dexamethasone and growth hormone treatment on hepatic gluconeogenic enzymes in calves. J Dairy Sci 2005; 88: 2107–2116.
View Full Article with Supporting Information (HTML) Get PDF (411K)